$19.14-0.05 (-0.23%)
The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients.
The Mosaic Company in the Basic Materials sector is trading at $19.14 with a market capitalization of $7.9B. Wall Street consensus targets $26.49 (18 analysts), implying a +38.5% move over the next 12 months. The stock is currently near its 52-week low of $18.41, remaining 20.1% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. Risk note: RSI 13 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.82B↓ | $3.00B↑ | $2.97B↓ | $3.45B↑ | $3.01B |
| Gross Profit | $214.70M↓ | $235.60M↓ | $342.60M↓ | $552.30M↑ | $518.60M |
| Operating Income | -$29.30M↑ | -$140.30M↓ | $156.00M↓ | $339.80M↑ | $244.40M |
| Net Income | -$272.80M↓ | -$257.60M↑ | -$519.50M↓ | $411.40M↑ | $410.70M |
The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients. It operates in three segments: Phosphates, Potash, and Mosaic Fertilizantes. The company owns and operates mines and production facil...
Academic risk and quality models computed from MOS's own filings and price history, not from analyst opinion.
Strong on 7 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, below the current 42.7% reading.
Fama-French 5-factor market beta. The five factors explain 9% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.